Legal status · Canada
Is Efocipegtrutide legal in Canada?
No. Efocipegtrutide is not approved for any medical use in Canada; its classification is "Investigational, not approved". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Preliminary.
Efocipegtrutide in Canada at a glance
| Classification | Investigational, not approved |
|---|---|
| Health Canada approval status | Not approved by Health Canada; investigational |
| Evidence level | Preliminary (research strength: Moderate) |
| Reviewed | Sep 2026 |
Classification and note come from the Efocipegtrutide profile, checked against Health Canada, Health Products and Food Branch (Health Canada) listings at the reviewed date.
What this means
- 01
Efocipegtrutide is being studied in registered clinical trials but has not received Health Canada marketing approval in Canada.
- 02
Lawful human access is limited to trial participation or a formal early-access scheme where one exists; there is no pharmacy product to prescribe.
- 03
Vials sold online "for research use only" are not trial material, and that label does not make human use lawful.
What Efocipegtrutide is
A triple GLP-1, GIP, and glucagon agonist developed mainly for metabolic liver disease.
Efocipegtrutide, also known as HM15211, is a long-acting triple agonist of the GLP-1, GIP, and glucagon receptors from Hanmi Pharmaceutical, developed with a particular focus on metabolic dysfunction-associated steatohepatitis (MASH). Like retatrutide it targets all three incretin-related pathways.
Mechanism: Agonizes GLP-1, GIP, and glucagon receptors, combining appetite, insulin, and energy-expenditure effects with liver-directed action.
Regulatory history: Investigational (Phase 2b in MASH completed mid-2026; results pending)
How Health Canada treats this kind of product
Authorises drugs for sale through a Notice of Compliance and Drug Identification Number. A compound that is not authorised for sale cannot lawfully be sold for human use, and personal importation of prescription drugs is limited.
The classification above is the The Longevity Archive reading of Health Canada, Health Products and Food Branch listings for Efocipegtrutide at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Efocipegtrutide in other countries
United States
InvestigationalInvestigational, not approved
Is Efocipegtrutide legal in the United States?United Kingdom
InvestigationalInvestigational, not licensed
Is Efocipegtrutide legal in the United Kingdom?Australia
InvestigationalInvestigational, not registered
Is Efocipegtrutide legal in Australia?Frequently asked questions
Is Efocipegtrutide legal in Canada?
No. Efocipegtrutide is not approved for any medical use in Canada; its classification is "Investigational, not approved". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Preliminary.
Can I buy Efocipegtrutide in Canada?
No approved product exists to buy. In Canada Efocipegtrutide is classified as "Investigational, not approved", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is Efocipegtrutide Health Canada approved?
No. In Canada Efocipegtrutide is classified as "Investigational, not approved", which is not a Health Canada marketing approval. For comparison, the US FDA status is: Investigational (Phase 2b in MASH completed mid-2026; results pending). Evidence level: Preliminary.
Related compounds in Canada
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Efocipegtrutide live on its compound profile.
Efocipegtrutide profileThis page is general information about the regulatory status of Efocipegtrutide in Canada, current as of Sep 2026. It is not legal advice, and classifications change; check Health Canada, Health Products and Food Branch directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.